CLINICAL TRIAL: P3 RAN DB -LETROZOLE VS PLAC PRIMARY BR CA COMPLETING 5 OR 5+ YR
CLINICAL TRIAL: P3 RAN DB -LETROZOLE VS PLAC PRIMARY BR CA COMPLETING 5 OR 5+ YR
批准号:
7951360
负责人:
CHRISTOPHER EHMANN
金额:
$0.79万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2010-03-31
中文摘要
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Preliminary research suggests cancer recurring may be reduced if letrozole is taken after five years of tamoxifen. The purpose of this study is to find out whether it is better to receive letrozole or no further treatment after stopping tamoxifen. The second purpose is to determine how the treatment affects the quality of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE
-
批准号:7951356
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2009
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
CLINICAL TRIAL: PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE
-
批准号:7951233
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2009
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
P3 RAN DB -LETROZOLE VS PLAC PRIMARY BR CA COMPLETING 5 OR 5+ YRS OF ADJ TAMOXIF
-
批准号:7625858
-
项目类别:
-
资助金额:$0.47万
-
财政年份:2007
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE TO STD THER FOL
-
批准号:7625854
-
项目类别:
-
资助金额:$0.22万
-
财政年份:2007
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE TO STD THER FOL
-
批准号:7625733
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2007
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE TO STD THER FOL
-
批准号:7378448
-
项目类别:
-
资助金额:$0.56万
-
财政年份:2006
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE TO STD THER FOL
-
批准号:7378554
-
项目类别:
-
资助金额:$0.39万
-
财政年份:2006
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
PHASE II: DOXIL CYCLOPHOSPHAMIDE,VINCRISTINE & PREDNISONE:AIDS SYSTEMIC LYMPHOMA
-
批准号:7378453
-
项目类别:
-
资助金额:$0.29万
-
财政年份:2006
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
P3 RAN DB -LETROZOLE VS PLAC PRIMARY BR CA COMPLETING 5 OR 5+ YRS OF ADJ TAMOXIF
-
批准号:7378558
-
项目类别:
-
资助金额:$0.39万
-
财政年份:2006
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
P3 RAN DB -LETROZOLE VS PLAC PRIMARY BR CA COMPLETING 5 OR 5+ YRS OF ADJ TAMOXIF
-
批准号:7203594
-
项目类别:
-
资助金额:$1.12万
-
财政年份:2005
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE TO STD THER FOL
-
批准号:7203466
-
项目类别:
-
资助金额:$1.16万
-
财政年份:2005
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
PHASE 3 STUDY:LOW GRADE LYMPH COMP CYCLOPHOSPHAMIDE/FLUDARABINE TO STD THER FOL
-
批准号:7203589
-
项目类别:
-
资助金额:$0.78万
-
财政年份:2005
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
PHASE 2/3 PACLITAXEL PLUS CARBOPLATIN W/WO BEVACIZUMAB IN NSCLC (ECOG E4599)
-
批准号:7203592
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2005
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
PHASE II: DOXIL CYCLOPHOSPHAMIDE,VINCRISTINE & PREDNISONE:AIDS SYSTEMIC LYMPHOMA
-
批准号:7203473
-
项目类别:
-
资助金额:$0.29万
-
财政年份:2005
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
Phase 3 Study:Low Grade Lymph Comp Cyclophosphamide/Fludarabine to Std Ther fol
-
批准号:7044375
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2003
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
Phase II--Doxil CVP in AIDS Systemic lymphoma
-
批准号:7044387
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2003
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
Phase 3 Study:Low Grade Lymph Comp Cyclophosphamide/Fludarabine to Std Ther fol
-
批准号:7044468
-
项目类别:
-
资助金额:$0.7万
-
财政年份:2003
-
负责人:CHRISTOPHER EHMANN
-
依托单位:
海外基金